Delcath Systems (DCTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Records 1 - 18 of 21 Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2019, EDGAR®Online, a division of Delcath Systems Stock Price Forecast, DCTHD stock price prediction. The best long-term & short-term Delcath Systems share price prognosis for 2020, 2021, YTD % Chg -60.71. 1 Year % Chg -95.89. Market Cap 873,240.00. Shares Outstanding 72,770.00. Beta 0.02. Dividend (Yield) -. Div Amount -. Ex Div Date -. DCTH: Get the latest Delcath Systems stock price and detailed information including DCTH news, historical charts and realtime prices. Get breaking news and analysis on Delcath Systems, Inc. (DCTH) stock, price quote and chart, trading and investing tools.
Delcath Systems (DCTH) Stock: The Good, The Bad, The Ugly ...
DCTH:OTC US Stock Quote - Delcath Systems Inc - Bloomberg ... Stock analysis for Delcath Systems Inc (DCTH:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock Quote For LLT:CNX - MicroSmallCap 10 Biggest Stock Price Target Changes for March 27 . Mar 27 microsmallcap. 5 Nasdaq Penny Stocks to Watch Next Week . Mar 27 Ankit Singhania. Rockwell Medical Receives FDA Approval: Stock Sees 6% Growth . Mar 27 Connor Doyle. 10 Biggest Stock Price Target Changes for March 26 . Delcath Systems, Inc. (NASDAQ:DCTH) has 1 year Price ... Mar 01, 2017 · According to Yahoo Finance, the price target for the company which analysts are aiming is 16. The 1-year price target of the company is 16. Considering the performance, Delcath Systems, Inc. (NASDAQ:DCTH)’s shares have the potential to reach a high EPS of -3.24 per share, and a low EPS of -3.24 per share in the current quarter. Delcath Systems (DCTH) Stock Price History | wallmine
Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21,
Delcath Systems Inc. DCTH Stock Message Board: DCTh target price Delcath Systems Inc. (DCTH) Stock Message Board - InvestorsHub About Delcath Systems (OTCQB:DCTH) Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Their proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. DCTH Stock Price and Chart — OTC:DCTH — TradingView View live DELCATH SYSTEMS, INC chart to track its stock's price action. Find market predictions, DCTH financials and market news. View live DELCATH SYSTEMS, INC chart to track its stock's price action. Find market predictions, DCTH financials and market news. TradingView . EN. DCTH trend reversal; target around $1.3; possible 20x+ rise DCTH - Delcath Systems Stock Price - Barchart.com Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21,